Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 5 Key Players companies in Peripheral neuropathy
by Most Market Reports in the United Kingdom in 2022

The Peripheral neuropathy top 5 is Discovery PatSnap’ annual ranking of the top 5 Most Market Reports Peripheral neuropathy Key Players in the United Kingdom. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2022, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
A disease affecting peripheral nerves.

Key Players

Fast-growings

Startups & Unicorns

New Entrants

Ranking Year:

2022

2021

2020

Region:

Global

China

Japan

India

United States

United Kingdom

Germany

France

Switzerland

South Korea

Ranking:

Most Patent Filings

Highest Patent Value

Most Patent Citation

Most Market Reports

Most News Heat

#
Company Name
Region
Tech Topics
Total
1
GSK Plc
United Kingdom
Health care,Clinical trial,Drug,
...[+2]
market report: 7
2
Smith & Nephew PLC
Herefordshire, United Kingdom
Sports medicine,Medical equipment,Medicine,
...[+2]
market report: 4
3
Mylan NV
Hertfordshire, United Kingdom
Transdermal patch,Medicine,Pharmacy,
...[+2]
market report: 4
4
AstraZeneca Plc
Cambridgeshire, United Kingdom
Medicine,Health care,Side effect,
...[+2]
market report: 2
5
Hikma Pharmaceuticals Plc
United Kingdom
Health care,Generic Product,Drug,
...[+2]
market report: 2

Who we serve

R&D Decision MakersNew Product Innovation LeaderTechnology Research AnalystsBusiness Development Professionals

Why Discovery

Technology Intelligence Data FoundationAI-powered Competitive Intelligence RadarTechnology Classification and Company Innovation Indicators

Social media

Try Discovery

Free Trial
PatSnap group products
Browse By:ABCDEFGHIJKLMNOPQRSTUVWXYZ#All topics,List of companies,Sitemap
© 2023 PatSnap. All rights reserved.Legal | Privacy policy Modern Slavery Act Transparency Statement
Page generation time: Jun 22 2025
For better visiting experience, please use PC device.X